• AZD2461: Novel PARP Inhibitor Enhancing Breast Cancer Workfl

  2026-05-09

  AZD2461 is a next-generation PARP inhibitor designed to overcome Pgp-mediated resistance and drive robust DNA repair pathway research in breast cancer models. This article provides actionable guidance—spanning experimental setup, workflow optimization, and troubleshooting—to help researchers fully harness AZD2461’s differentiated advantages.

• QRICH1 Drives HBV-Induced HMGB1 Secretion via ER Stress in H

  2026-05-08

  This study uncovers how QRICH1 amplifies HBV-driven hepatic fibrosis by enhancing HMGB1 translocation and secretion through endoplasmic reticulum stress. Mechanistic insights into SIRT6 modulation and HMGB1 acetylation offer new perspectives for targeting inflammation and fibrosis in chronic liver disease.

• Mutually Antagonistic m6A Modification in Plant-Virus Intera

  2026-05-08

  This study reveals a dynamic antagonistic mechanism involving m6A RNA modifications during the interaction between Arabidopsis and Cucumber mosaic virus (CMV). By mapping the roles of methyltransferases, reader proteins, and viral suppressors, the research uncovers key regulatory layers in plant antiviral defense and viral counterstrategies, with implications for future plant protection research.

• Applied Workflows with Cholecystokinin Octapeptide Ammonium

  2026-05-07

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) empowers precise neurobehavioral, immune, and apoptosis assays with context- and concentration-dependent effects. This article distills experimental insights, protocol enhancements, and troubleshooting strategies—bridging recent zebrafish anxiety models and advanced neuronal/apoptosis paradigms.

• Chenodeoxycholic Acid (CDCA): Precision Tool for FXR Signali

  2026-05-07

  Explore the advanced scientific role of Chenodeoxycholic Acid (CDCA) in FXR-mediated nuclear receptor signaling and cholesterol metabolism research. This article delivers unique protocol insights and practical guidance, building on recent breakthroughs in assay design.

• Coumestrol in Rheumatoid Arthritis: Mechanistic Insights and

  2026-05-06

  Explore how Coumestrol, a potent phytoestrogen estrogen receptor antagonist, uniquely induces ferroptosis in rheumatoid arthritis models. Gain actionable, assay-level insight into Coumestrol's distinct mechanisms and best research applications.

• AG-490 (Tyrphostin B42): Applied JAK2/EGFR Inhibition in Can

  2026-05-06

  AG-490 (Tyrphostin B42) empowers cancer and immunopathology research by enabling precise inhibition of JAK2/STAT and MAPK pathways. This article translates recent advances—like exosomal SNORD52-driven macrophage polarization—into actionable protocols, troubleshooting strategies, and best practices for reproducible experimentation.

• Exosomal SNORD52 Drives M2 Macrophage Polarization via JAK2/

  2026-05-05

  This study reveals that hepatoma cell-derived exosomal SNORD52 promotes M2 macrophage polarization by activating the JAK2/STAT6 pathway. These findings highlight the importance of exosomal snoRNAs in shaping the tumor immune microenvironment of hepatocellular carcinoma and suggest potential avenues for targeted intervention.

• Estradiol in Experimental Research: Protocols and Pitfalls

  2026-05-05

  Estradiol (17 beta-estradiol) is pivotal for modeling estrogen receptor and autophagy signaling in organ protection studies. This guide delivers actionable workflow steps, protocol optimizations, and troubleshooting strategies using APExBIO’s Estradiol for advanced cardiovascular, metabolic, and endocrine research.

• Toremifene vs Tamoxifen in Advanced Breast Cancer: Systemati

  2026-05-04

  This systematic review compared the efficacy and safety of Toremifene Citrate and Tamoxifen in advanced breast cancer. The findings demonstrate equivalent therapeutic outcomes, offering robust evidence for clinical and research selection of oral selective estrogen receptor modulators.

• Prochlorperazine: Dopamine D2 Receptor Antagonist in Researc

  2026-05-04

  Prochlorperazine's unique multi-receptor profile enables advanced cancer, antiviral, and antiemetic research, making it a versatile tool for cellular assays and disease modeling. This article demystifies applied protocols, troubleshooting, and workflow innovations with APExBIO’s high-quality reagent, all while translating the latest clinical vigilance insights into practical laboratory safeguards.

• Prochlorperazine: Dopamine D2 Antagonist in Melanoma Researc

  2026-05-03

  Prochlorperazine's multi-receptor targeting offers translational researchers a unique tool for both antiemetic therapy and mechanistic cancer research. This guide details robust experimental workflows and troubleshooting strategies, empowering labs to harness its full potential for melanoma assays and beyond.

• Dual Recombinase Tracing Refutes Postnatal Neo-oogenesis in

  2026-05-02

  This study applies a dual recombinase-mediated genetic tracing system to rigorously assess whether new oocytes are formed in mice after birth, both under normal conditions and following ovarian injury. The findings demonstrate a lack of postnatal neo-oogenesis, refining our understanding of mammalian reproductive biology and informing future experimental models.

• BMS 599626 dihydrochloride: Precision EGFR/ErbB2 Inhibition

  2026-05-01

  BMS 599626 dihydrochloride empowers researchers to dissect EGFR and ErbB2 signaling with nanomolar precision, optimizing cancer cell proliferation inhibition and tumor growth suppression in preclinical models. Explore robust, evidence-based workflows, troubleshooting strategies, and cross-validated insights for translational breast and lung cancer research.

• AG-490 (JAK2/EGFR inhibitor): Reproducible Solutions for Cel

  2026-05-01

  This authoritative guide explores how AG-490 (JAK2/EGFR inhibitor, SKU A4139) addresses core challenges in cell viability and signaling pathway assays. Using scenario-driven Q&A, we demonstrate its validated performance in JAK-STAT and MAPK pathway inhibition, reliable data interpretation, and vendor selection, providing actionable strategies for biomedical researchers.

15926 records 1/1062 page Next 12345 下5页 Last page